Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468K Buy
235
+26
+12% +$41.4K 0.08% 78
2026
Q1
$276K Buy
209
+6
+3% +$8.22K 0.05% 99
2025
Q4
$217K Sell
203
-8
-4% -$8.35K 0.04% 102
2025
Q3
$204K Buy
+211
New +$166K 0.04% 101
2024
Q3
Sell
-238
Closed -$243K 115
2024
Q2
$243K Sell
238
-70
-23% -$67.3K 0.06% 99
2024
Q1
$299K Sell
308
-20
-6% -$17.7K 0.07% 87
2023
Q4
$248K Buy
+328
New +$217K 0.06% 95
2023
Q3
Sell
-328
Closed -$238K 96
2023
Q2
$238K Hold
328
0.07% 97
2023
Q1
$223K Buy
+328
New +$211K 0.07% 100
2022
Q2
Sell
-348
Closed -$232K 94
2022
Q1
$232K Hold
348
0.06% 95
2021
Q4
$277K Buy
+348
New +$276K 0.07% 82

Other funds holding ASML

M. Kulyk & Associates's ASML Position: Q2 2026 in Review

M. Kulyk & Associates increased its ASML (ASML) stake by 12% in Q2 2026, buying an estimated $41.4K and bringing the position to 235 shares worth $468K. The position accounts for 0.08% of the portfolio, ranked #78.

M. Kulyk & Associates first reported a position in ASML in Q4 2021 and has held it in 11 quarters since. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • M. Kulyk & Associates held 235 shares of ASML worth $468K as of Q2 2026.
  • M. Kulyk & Associates bought 26 ASML shares in Q2 2026, an estimated $41.4K.
  • ASML made up 0.08% of M. Kulyk & Associates's portfolio in Q2 2026, its #78 holding.
  • M. Kulyk & Associates first reported a position in ASML in Q4 2021 and has held it in 11 quarters since.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on M. Kulyk & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.